Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study.

Chappell FM, Del Carmen Valdés Hernández M, Makin SD, Shuler K, Sakka E, Dennis MS, Armitage PA, Muñoz Maniega S, Wardlaw JM.

Trials. 2017 Feb 21;18(1):78. doi: 10.1186/s13063-017-1825-7.

2.

White Matter Hyperintensity-Associated Blood-Brain Barrier Disruption and Vascular Risk Factors.

Gupta N, Simpkins AN, Hitomi E, Dias C, Leigh R; NIH Natural History of Stroke Investigators.

J Stroke Cerebrovasc Dis. 2018 Feb;27(2):466-471. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.026. Epub 2017 Oct 31.

3.

Correlation between Fibrinogen and White Matter Hyperintensities among Nondiabetic Individuals with Noncardiogenic Ischemic Stroke.

You CJ, Liu D, Liu LL, Liu QQ, Li GZ.

J Stroke Cerebrovasc Dis. 2018 Sep;27(9):2360-2366. doi: 10.1016/j.jstrokecerebrovasdis.2018.04.025.

PMID:
29773351
4.

White matter hyperintensity reduction and outcomes after minor stroke.

Wardlaw JM, Chappell FM, Valdés Hernández MDC, Makin SDJ, Staals J, Shuler K, Thrippleton MJ, Armitage PA, Muñoz-Maniega S, Heye AK, Sakka E, Dennis MS.

Neurology. 2017 Sep 5;89(10):1003-1010. doi: 10.1212/WNL.0000000000004328. Epub 2017 Aug 9.

5.

White Matter Hyperintensity-Adjusted Critical Infarct Thresholds to Predict a Favorable 90-Day Outcome.

Patti J, Helenius J, Puri AS, Henninger N.

Stroke. 2016 Oct;47(10):2526-33. doi: 10.1161/STROKEAHA.116.013982. Epub 2016 Sep 15.

6.

Relationship Between White Matter Hyperintensities Penumbra and Cavity Formation.

Zhang X, Ding L, Yang L, Qin W, Li Y, Li S, Hu W.

Med Sci Monit. 2016 Jan 5;22:41-9.

7.

Long-term progression of white matter hyperintensities in ischemic stroke.

Holmegaard L, Jensen C, Redfors P, Blomstrand C, Jern C, Jood K.

Acta Neurol Scand. 2018 Dec;138(6):548-556. doi: 10.1111/ane.13019. Epub 2018 Sep 24.

PMID:
30152523
8.

Differential impact of white matter hyperintensities on long-term outcomes in ischemic stroke patients with large artery atherosclerosis.

Baik M, Kim K, Yoo J, Kim HC, Jeong SH, Kim KH, Park HJ, Kim YD, Heo JH, Nam HS.

PLoS One. 2017 Dec 12;12(12):e0189611. doi: 10.1371/journal.pone.0189611. eCollection 2017.

9.

Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities.

Tosto G, Zimmerman ME, Carmichael OT, Brickman AM; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Neurol. 2014 Jul 1;71(7):872-7. doi: 10.1001/jamaneurol.2014.667.

10.

Do Lacunar Infarcts Have Different Aetiologies? Risk Factor Profiles of Lacunar Infarcts in Deep White Matter and Basal Ganglia: The Second Manifestations of ARTerial Disease-Magnetic Resonance Study.

Kloppenborg RP, Nederkoorn PJ, Grool AM, De Cocker LJ, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Cerebrovasc Dis. 2017;43(3-4):161-168. doi: 10.1159/000454782. Epub 2017 Jan 31.

11.

Association of White Matter Hyperintensities With Short-Term Outcomes in Patients With Minor Cerebrovascular Events.

Zerna C, Yu AYX, Modi J, Patel SK, Coulter JI, Smith EE, Coutts SB.

Stroke. 2018 Apr;49(4):919-923. doi: 10.1161/STROKEAHA.117.017429. Epub 2018 Mar 14.

PMID:
29540612
12.

White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction.

Andersen SD, Larsen TB, Gorst-Rasmussen A, Yavarian Y, Lip GY, Bach FW.

Cerebrovasc Dis. 2017;43(1-2):17-24. doi: 10.1159/000450962. Epub 2016 Oct 18.

PMID:
27750251
13.

Metric to quantify white matter damage on brain magnetic resonance images.

Valdés Hernández MDC, Chappell FM, Muñoz Maniega S, Dickie DA, Royle NA, Morris Z, Anblagan D, Sakka E, Armitage PA, Bastin ME, Deary IJ, Wardlaw JM.

Neuroradiology. 2017 Oct;59(10):951-962. doi: 10.1007/s00234-017-1892-1. Epub 2017 Aug 16.

14.

On the computational assessment of white matter hyperintensity progression: difficulties in method selection and bias field correction performance on images with significant white matter pathology.

Valdés Hernández Mdel C, González-Castro V, Ghandour DT, Wang X, Doubal F, Muñoz Maniega S, Armitage PA, Wardlaw JM.

Neuroradiology. 2016 May;58(5):475-85. doi: 10.1007/s00234-016-1648-3. Epub 2016 Jan 30.

15.

Cilostazol decreases cerebral arterial pulsatility in patients with mild white matter hyperintensities: subgroup analysis from the Effect of Cilostazol in Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler (ECLIPse) study.

Han SW, Song TJ, Bushnell CD, Lee SS, Kim SH, Lee JH, Kim GS, Kim OJ, Koh IS, Lee JY, Suk SH, Lee SI, Nam HS, Kim WJ, Lee KY, Park JH, Kim JY, Park JH.

Cerebrovasc Dis. 2014;38(3):197-203. doi: 10.1159/000365840. Epub 2014 Oct 9.

PMID:
25300977
16.

Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.

Molad J, Kliper E, Korczyn AD, Ben Assayag E, Ben Bashat D, Shenhar-Tsarfaty S, Aizenstein O, Shopin L, Bornstein NM, Auriel E.

J Alzheimers Dis. 2017;56(4):1293-1299. doi: 10.3233/JAD-160939.

PMID:
28157096
17.

White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.

Prasad K, Wiryasaputra L, Ng A, Kandiah N.

Dement Geriatr Cogn Disord. 2011;31(6):431-4. doi: 10.1159/000330019. Epub 2011 Jul 15.

PMID:
21757908
18.

White matter hyperintensity and stroke lesion segmentation and differentiation using convolutional neural networks.

Guerrero R, Qin C, Oktay O, Bowles C, Chen L, Joules R, Wolz R, Valdés-Hernández MC, Dickie DA, Wardlaw J, Rueckert D.

Neuroimage Clin. 2017 Dec 20;17:918-934. doi: 10.1016/j.nicl.2017.12.022. eCollection 2018.

19.

Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.

Gouw AA, van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Scheltens P, Barkhof F; LADIS Study Group.

Stroke. 2008 May;39(5):1414-20. doi: 10.1161/STROKEAHA.107.498535. Epub 2008 Mar 6.

PMID:
18323505
20.

Cystatin C, a potential marker for cerebral microvascular compliance, is associated with white-matter hyperintensities progression.

Lee WJ, Jung KH, Ryu YJ, Kim JM, Lee ST, Chu K, Kim M, Lee SK, Roh JK.

PLoS One. 2017 Sep 14;12(9):e0184999. doi: 10.1371/journal.pone.0184999. eCollection 2017.

Supplemental Content

Support Center